General Information
BounceWatch is an independent company data service, not affiliated with ENDECE. To contact ENDECE, visit endece.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ENDECE compare?
A PDF of ENDECE and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ENDECE soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About ENDECE
Business keywords: biopharmaceutical company, drug discovery, therapeutic modalities, SARS-CoV-2, COVID-19, respiratory system, inflammation, proprietary compounds, disease treatment, multiple sclerosis, Alzheimer's disease, clinical development, biological pathways, gain of function, disease research
Funding Rounds & Investors (3)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Funding Round | $1.20M | - |
|
20 Jul 2011 |
| Grant | $244.48K | - |
|
01 Nov 2010 |
| Funding Round | $6.00M | - |
|
01 Jan 2009 |
ENDECE Alternatives & Competitors
View All AlternativesPrecision therapeutics for protein misfolding disorders, including Alzheimer's, ALS and Parkinson’s...
Advancing therapeutic innovation in human cell signaling for inflammation, fibrosis, and CNS disease...
Fighting COVID-19 with fully human neutralizing antibodies
FAQ About ENDECE
Source: BounceWatch company record for ENDECE, https://bouncewatch.com/company/endece, updated 14 January 2025. When citing, please name BounceWatch and link this page.